Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC189 tablets in adolescents and adults with uncomplicated acute influenza
CTR20230137Phase 3Completed
- Sponsor
- Jiaxing AnDiCon Biotech
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing ADC189 tablets with Placebo tablets (2 arms). Started Mar 2023; status: completed.
02
Drugs
deunoxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20230137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230137.